From Agios to Deciphera, Steve Hoerter plots another oncology launch; Roche exec Christiane Hamachar moves to India as CEO of Biocon Biologics
→ Deciphera $DCPH has scooped Agios’ chief commercial officer Steve Hoerter to fill retiring CEO Michael Taylor’s shoes. The Waltham, MA-based biotech is placing its trust in Hoerter’s sales acumen, especially for cancer drugs, acquired throughout his career at companies like Clovis, Roche, Genentech, Chiron, and Eli Lilly. The first Phase III trial of ripretinib, in gastrointestinal tumors, is due to read out soon.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
